|
Regulation of actin cytoskeleton
|
2.51
|
0.001
|
2.75
|
0.001
|
|
Chemokine signaling pathway
|
2.48
|
0.001
|
2.56
|
0.001
|
|
JAK-STAT signaling pathway
|
2.39
|
0.001
|
2.55
|
0.001
|
|
Integrin cell surface interactions
|
2.46
|
0.001
|
2.5
|
0.001
|
|
Cell adhesion molecules
|
2.31
|
0.001
|
2.38
|
0.001
|
|
Integrin signaling pathway
|
2.28
|
0.001
|
2.37
|
0.001
|
|
Cell surface interactions at the vascular wall
|
2.27
|
0.001
|
2.33
|
0.001
|
|
Signal transduction by L1
|
2.24
|
0.007
|
2.27
|
0.007
|
|
Cytokine cytokine receptor interaction
|
2.20
|
0.008
|
2.25
|
0.007
|
|
Apoptosis by serum deprivation up
|
2.17
|
0.008
|
2.23
|
0.007
|
|
Immortalized by HPV31 DN
|
2.16
|
0.008
|
2.23
|
0.008
|
|
Signaling by FGFR1 mutants
|
2.14
|
0.011
|
2.21
|
0.010
|
|
TNF signaling up
|
2.12
|
0.014
|
2.19
|
0.013
|
|
ECM receptor interaction
|
2.10
|
0.025
|
2.13
|
0.021
|
|
TRAF trafficking pathway
|
2.08
|
0.013
|
2.12
|
0.011
|
|
Leukocyte transendothelial migration
|
2.04
|
0.008
|
2.14
|
0.007
|
